Filter by tags: South Korea China United States Severe acute respiratory syndrome coronavirus 2 Clear all tag filters
3 news articles found
The International Thermonuclear Experimental Reactor (ITER) project says that the impact of COVID-19 means that its current schedule, of first plasma in 2025 and the start of deuterium-tritium operation in 2035, will need to be delayed, with the new timetable to be finalised and announced after the appointment of a new director general.
- Source: World Nuclear News
- Date: Tuesday, 12 July 2022
- Original article: world-nuclear-news.org/Articles/ITER-fusion-project-preparing-to-outline-revised-t
Dr Bernard Bigot, Director-General of the Iter Organisation passed away on 14 May “due to illness”. Iter said he was “an inspirational leader for more than four decades across multiple fields of science and energy” and that his personal dedication and commitment to Iter over the past seven years shaped every aspect of the project”. Iter added: “While his untimely passing will be felt as a tragic blow to the global fusion community, Dr Bigot’s careful design and preparation of the Iter senior management team in recent years gives reassurance of the project’s continued success.”
- Source: NEI Magazine
- Date: Tuesday, 17 May 2022
- Original article: neimagazine.com/news/newsiter-director-general-bernard-bigot-dies-9701551
The COVID-19 pandemic has created an unprecedented demand for personal protective equipment (PPE), part of which must be sterile, i.e. exempt from any microorganism such as bacteria or moulds that can compromise the wearer’s or the patient's safety. It was realised that whilst irradiation is routinely used to sterilise medical products it might also be possible to use the technology to increase the available supply of PPE, writes Paul Wynne, chairman of the International Irradiation Association.
- Source: World Nuclear News
- Date: Wednesday, 06 May 2020
- Original article: world-nuclear-news.org/Articles/Viewpoint-Using-irradiation-to-treat-PPE